You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 17, 2024

Details for Patent: 9,309,234


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,309,234 protect, and when does it expire?

Patent 9,309,234 protects OLINVYK and is included in one NDA.

This patent has fifty-one patent family members in twenty-three countries.

Summary for Patent: 9,309,234
Title:Opioid receptor ligands and methods of using and making same
Abstract: This application describes compounds that can act as opioid receptor ligands, which compounds can be used in the treatment of, for example, pain and pain related disorders.
Inventor(s): Yamashita; Dennis (Cambridge, MA), Gotchev; Dimitar (Hatboro, PA), Pitis; Philip (North Wales, PA), Chen; Xiao-Tao (Furlong, PA), Liu; Guodong (Jamison, PA), Yuan; Catherine C. K. (King of Prussia, PA)
Assignee: Trevena, Inc. (King of Prussia, PA)
Application Number:14/712,974
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;

Drugs Protected by US Patent 9,309,234

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Trevena OLINVYK oliceridine SOLUTION;INTRAVENOUS 210730-001 Oct 30, 2020 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y Y MANAGEMENT OF ACUTE PAIN BY INTRAVENOUS INJECTION ⤷  Try a Trial
Trevena OLINVYK oliceridine SOLUTION;INTRAVENOUS 210730-002 Oct 30, 2020 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y Y MANAGEMENT OF ACUTE PAIN BY INTRAVENOUS INJECTION ⤷  Try a Trial
Trevena OLINVYK oliceridine SOLUTION;INTRAVENOUS 210730-003 Oct 30, 2020 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y Y MANAGEMENT OF ACUTE PAIN BY INTRAVENOUS INJECTION ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,309,234

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2012230761 ⤷  Try a Trial
Australia 2017200745 ⤷  Try a Trial
Brazil 112013024136 ⤷  Try a Trial
Canada 2830742 ⤷  Try a Trial
China 103702561 ⤷  Try a Trial
Cyprus 1119057 ⤷  Try a Trial
Denmark 2688403 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.